Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Treatment
Chemotherapy-related bone loss is attenuated by tamoxifen treatment
November 24th, 2005
Adjuvant chemotherapy-related bone loss is attenuated by one year of tamoxifen treatment. "Adjuvant therapies have prolonged survival of non-metastatic breast cancer (NMBC) patients, but they also decrease bone mineral density (BMD)," scientists writing in the journal Breast Cancer Research and Treatment reported. They "have analyzed the effects of chemotherapy, hormone therapy with tamoxifen or both, on BMD of women with NMBC." L.M. Rodriguez-Rodriguez and colleagues "prospectively included 168 women with NMBC (stage I-III) referred to the Medical Oncology Service of University Hospital of Canary Islands between 1997 and 2001 (55±12...
Source: Women's Health Weekly (2005-11-24)
|
